Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery.
$4.28
As of 04/09/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.